NCT05166902 is a NA clinical trial of Lens A (comfilcon A lens) in Ametropia, sponsored by CooperVision, Inc..

Who is sponsoring NCT05166902?

NCT05166902 is sponsored by CooperVision, Inc..

What drugs are being tested in NCT05166902?

Interventions in NCT05166902: Lens A (comfilcon A lens), Lens B (lehfilcon A lens).

Is NCT05166902 still recruiting?

NCT05166902 is currently completed. Last updated 27 July 2023.

Are results published for NCT05166902?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-07-27 · How we verify

NCT05166902

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use

Completed NA Results posted Last updated 27 July 2023

What this trial tests

NA trial testing Lens A (comfilcon A lens) in Ametropia in 67 participants. Completed in 9 July 2022.

Timeline

31 January 2022

Primary endpoint
9 July 2022

9 July 2022

Quick facts

Lead sponsor	CooperVision, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	67
Start date	31 January 2022
Primary completion	9 July 2022
Estimated completion	9 July 2022
Sites	4 locations across Canada, United States

Drugs / interventions tested

Lens A (comfilcon A lens)
Lens B (lehfilcon A lens)

Conditions studied

Ametropia — all drugs for Ametropia →

Sponsor

CooperVision, Inc.

Who can join

Adults 18 to 35, any sex, with Ametropia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Subjective Ratings on Lens Handling on Removal Primary · Day 27

Subjective ratings on lens handling on removal will be measured on a scale of 0-10, 0.5 steps (10= Very Easy, 0= Very Difficult)

Group	Value	95% CI
Lens A	8.3	± 1.8
Lens B	8.8	± 1.2

Adverse events — posted to ClinicalTrials.gov

Time frame: From dispense up to one month on each study lens, for total of two months. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Lens A

Serious: 0/66 (0%)

Deaths: 0/66

Lens B

Serious: 0/66 (0%)

Deaths: 0/66

Other adverse events (3 terms — click to expand)

Reaction	System	Lens A	Lens B
COVID-19	Social circumstances	—	—
Lens discomfort	Product Issues	—	—
Sinus	Infections and infestations	—	—

Data from ClinicalTrials.gov NCT05166902 adverse events section.

Sponsor's own description

To evaluate the clinical performance of two monthly silicone hydrogel contact lenses in habitual wearers of frequent replacement (FRP) lenses when worn for 1-month.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lens A (comfilcon A lens)

Trials testing the same drug.

NCT05313412 — Clinical Evaluation of Two Silicone Hydrogel Contact Lenses · NA · completed
NCT05114564 — Evaluation of the Performance of Monthly Replacement Sphere Lens Designs in Habitual Soft Contact Lens Wearers · NA · completed

Other recruiting trials for Ametropia

Currently open trials in the same condition.

NCT06668246 — Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS) · active not recruiting
NCT04632784 — Clinical Trial With Artiflex Presbyopic (Artiplus) · NA · active not recruiting

Other CooperVision, Inc. trials

Trials by the same sponsor.

NCT06817785 — Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere · NA · completed
NCT06758076 — A Clinical Comparison of Two Soft Contact Lenses (C24-755) · NA · completed
NCT06590441 — Investigation of Wearing Compliance of Spectacles for Myopia Control · completed
NCT06609018 — Clinical Investigation of Buttermere (LENS 271) Soft Contact Lenses · NA · completed
NCT06611410 — 1 Week Crossover Study Between Two Soft Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05166902 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision, Inc.
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05166902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing